These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20391423)

  • 21. Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome.
    Levesque K; Morel N; Maltret A; Baron G; Masseau A; Orquevaux P; Piette JC; Barriere F; Le Bidois J; Fermont L; Fain O; Theulin A; Sassolas F; Pezard P; Amoura Z; Guettrot-Imbert G; Le Mercier D; Georgin-Lavialle S; Deligny C; Hachulla E; Mouthon L; Ravaud P; Villain E; Bonnet D; Costedoat-Chalumeau N; ;
    Autoimmun Rev; 2015 Dec; 14(12):1154-60. PubMed ID: 26284740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A serologic marker for fetal risk of congenital heart block.
    Salomonsson S; Dörner T; Theander E; Bremme K; Larsson P; Wahren-Herlenius M
    Arthritis Rheum; 2002 May; 46(5):1233-41. PubMed ID: 12115229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices.
    Clowse MEB; Eudy AM; Kiernan E; Williams MR; Bermas B; Chakravarty E; Sammaritano LR; Chambers CD; Buyon J
    Rheumatology (Oxford); 2018 Jul; 57(suppl_5):v9-v17. PubMed ID: 30137589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two case reports of neonatal autoantibody-associated congenital heart block.
    Li X; Huang X; Lu H
    Medicine (Baltimore); 2018 Nov; 97(45):e13185. PubMed ID: 30407356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
    Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
    Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Obstetrical management of patients at risk of neonatal lupus syndrome: review of the literature].
    Costedoat-Chalumeau N; Amoura Z; Villain E; Cohen L; Fermont L; Le Thi Huong D; Vauthier D; Georgin-Lavialle S; Wechsler B; Dommergues M; Piette JC
    J Gynecol Obstet Biol Reprod (Paris); 2006 Apr; 35(2):146-56. PubMed ID: 16575360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital heart block related to maternal autoantibodies: descriptive analysis of a series of 18 cases from a single center.
    Doti PI; Escoda O; Cesar-Díaz S; Palasti S; Teixidó I; Sarquella-Brugada G; Gómez O; Martínez JM; Espinosa G
    Clin Rheumatol; 2016 Feb; 35(2):351-6. PubMed ID: 26791874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus.
    Silverman ED; Buyon J; Laxer RM; Hamilton R; Bini P; Chu JL; Elkon KB
    Clin Exp Immunol; 1995 Jun; 100(3):499-505. PubMed ID: 7774062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of congenital heart block in children of SSA-positive mothers.
    Brucato A
    Rheumatology (Oxford); 2008 Jun; 47 Suppl 3():iii35-7. PubMed ID: 18504284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases.
    Fredi M; Argolini LM; Angeli F; Trespidi L; Ramoni V; Zatti S; Vojinovic T; Donzelli D; Gazzola FG; Xoxi B; Andreoli L; Lojacono A; Ferrazzi E; Montecucco C; Chighizola CB; Meroni PL; Franceschini F; Cimaz R; Caporali R; Tincani A; Gerosa M
    Clin Exp Rheumatol; 2023 Mar; 41(3):685-693. PubMed ID: 36377571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus.
    Saleeb S; Copel J; Friedman D; Buyon JP
    Arthritis Rheum; 1999 Nov; 42(11):2335-45. PubMed ID: 10555029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjögren's syndrome A/Ro antibody.
    Yang CH; Chen JY; Lee SC; Luo SF
    J Microbiol Immunol Infect; 2005 Oct; 38(5):365-9. PubMed ID: 16211147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus.
    Askanase AD; Izmirly PM; Katholi M; Mumtaz J; Buyon JP
    Lupus; 2010 Mar; 19(3):300-6. PubMed ID: 20008445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La.
    Julkunen H; Kurki P; Kaaja R; Heikkilä R; Immonen I; Chan EK; Wallgren E; Friman C
    Arthritis Rheum; 1993 Nov; 36(11):1588-98. PubMed ID: 8240435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies.
    Tsuboi H; Sumida T; Noma H; Yamagishi K; Anami A; Fukushima K; Horigome H; Maeno Y; Kishimoto M; Takasaki Y; Nakayama M; Waguri M; Sago H; Murashima A
    Mod Rheumatol; 2016 Jul; 26(4):569-75. PubMed ID: 26457409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal congenital heart block.
    Yildirim A; Tunaoolu FS; Karaaoac AT
    Indian Pediatr; 2013 May; 50(5):483-8. PubMed ID: 23778728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen.
    Claus R; Hickstein H; Külz T; Lenschow U; Meiske D; Kotitschke A; Thiesen HJ; Lorenz P
    Rheumatol Int; 2006 Aug; 26(10):886-95. PubMed ID: 16402218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combination therapy to treat second-degree anti-Ro/La-related congenital heart block: a strategy to avoid stable third-degree heart block?
    Ruffatti A; Milanesi O; Chiandetti L; Cerutti A; Gervasi MT; De Silvestro G; Pengo V; Punzi L
    Lupus; 2012 May; 21(6):666-71. PubMed ID: 22187163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.
    Skog A; Lagnefeldt L; Conner P; Wahren-Herlenius M; Sonesson SE
    Acta Obstet Gynecol Scand; 2016 Jan; 95(1):98-105. PubMed ID: 26411741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
    Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
    J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.